. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Angiosarcoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Iron Deficiency Anemia.

Malin Hultcrantz is a Hematologist and an Oncologist in New York, New York. Dr. Hultcrantz is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, Myeloproliferative Neoplasms (MPN), and Bone Marrow Aspiration. Dr. Hultcrantz is currently accepting new patients.

Sham Mailankody is a Hematologist and an Oncologist in New York, New York. Dr. Mailankody is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Mailankody is currently accepting new patients.

Jens Hillengass is an Oncologist and a Hematologist in Buffalo, New York. Dr. Hillengass is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.

. Dr. Parylo is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Leukocytosis, and Small Cell Lung Cancer (SCLC).

. Dr. Allerton is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer.

Joshua Raff, M.D. is the Director of the Digestive Cancer Program at White Plains Hospital, as well as the Leader of the Hospital's GI Cancer Program Conference. Dr. Raff received his medical degree from the Sackler School of Medicine at Tel Aviv University in 1997. He completed his residency in internal medicine at Montefiore Medical Center in the Bronx, and was a fellow of hematology and oncology at Albert Einstein College of Medicine from 2000-2003. Dr. Raff is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Chronic Lymphocytic Leukemia (CLL), and Colorectal Cancer.

Heather Landau is a Hematologist and an Oncologist in New York, New York. Dr. Landau is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Primary Amyloidosis, Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Cardiac Amyloidosis, and Bone Marrow Transplant. Dr. Landau is currently accepting new patients.

Anna Komorowski is a Hematologist and an Oncologist in Sleepy Hollow, New York. Dr. Komorowski is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

Dr. Dan Costin is Director of the White Plains Hospital Center for Cancer Care. He has been practicing medical oncology and hematology in Westchester since 1993. He received his B.S. in biochemistry at the University of California in Los Angeles and his medical degree at the University of California in San Francisco. He completed his internal medicine residency at Beth Israel Hospital in Boston in 1990, his fellowship in medical oncology at the National Cancer Institute in Bethesda in 1991, and his fellowship in hematology at New York University in 1993. He has been an attending physician at White Plains Hospital since 1993 and served as section chief of the department of Hematology-Oncology from 1999 to 2007. Dr. Costin is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Paget Disease of the Breast, Chondrosarcoma, Osteosarcoma, and Angiosarcoma.

Ruben Niesvizky is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Niesvizky is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Samir Parekh is a Hematologist and an Oncologist in New York, New York. Dr. Parekh is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Mantle Cell Lymphoma (MCL), and Bone Marrow Transplant. Dr. Parekh is currently accepting new patients.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration.

Dr. Yael Zack is a member of White Plains Hospital Physician Associates, Oncology & Hematology of White Plains. Dr. Zack is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Anemia, Paget Disease of the Breast, Large-Cell Immunoblastic Lymphoma, and Familial Colorectal Cancer.

Avi Einzig is an Oncologist in Bronx, New York. Dr. Einzig is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Pleuropulmonary Blastoma, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Dr. Karen Green graduated from New York University School of Medicine in 1988 and received residency training in Internal Medicine at The New York Hospital/Cornell Medical Center and Memorial Sloan Kettering Cancer Center. She completed a fellowship in Hematology/Oncology at New York Presbyterian Hospital/Cornell Medical Center. After completing her training in 1995, she spent eight years on the full-time faculty at New York Presbyterian Hospital/Cornell Medical Center, where she served as Assistant Professor of Medicine and specialized in breast cancer. Dr. Green is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Daniel T. Friedman, MD, is Director, Community Hematology/Oncology at Montefiore Einstein and Assistant Professor, Medical Oncology at our Albert Einstein College of Medicine. He delivers community-focused care for hematology and medical oncology patients in the Bronx and Yonkers. Dr. Friedman is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Acquired Agranulocytosis, Myelodysplastic Syndrome (MDS), Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and Endoscopy.

Hani Hassoun is a Hematologist and an Oncologist in New York, New York. Dr. Hassoun is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Hassoun is currently accepting new patients.

Suzanne Lentzsch is a Hematologist in New York, New York. Dr. Lentzsch is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Tissue Biopsy. Dr. Lentzsch is currently accepting new patients.

Alexander Lesokhin is a Hematologist and an Oncologist in New York, New York. Dr. Lesokhin is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Lesokhin is currently accepting new patients.